Masibulele Pharmaceuticals (Pty) Ltd.

Masibulele Pharmaceuticals was formed in 2005. It’s major investment is in Aspen Pharmacare Holdings Ltd. (“Aspen”) through Imithi Investments (Pty) Ltd. Masibulele holds 17.6% in Imithi Investments (Pty) Ltd, the Special Purpose Vehicle used to invest in Aspen. Judy Dlamini, the founder of Masibulele chairs the board of Aspen and is also a member of the Remuneration and Social & Ethics committees.